The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...
The U.S. Food and Drug Administration on Friday approved a new ​formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ‌scanning access through increased production ...
Interesting Engineering on MSN
Robot performs prostate surgery across 1,500 miles between London and Gibraltar
A surgeon in London has successfully removed a patient’s prostate in Gibraltar using a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results